Youngevity International, Inc. Reports Record Revenues for the Year Ended December 31, 2016

Revenues Increased 3.9% Year-Over-Year Gross Profit Increased by 5.6% Shareholder Conference Call at 4:15 EDT

Continue Reading

Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016

Sales of Flagship Rapid HIT Test +85% over 2015

Continue Reading

Cre8tive Works Signs Letter of Intent to Develop Horror Film

NEW YORK, NY -- (Marketwired) -- 03/30/17 -- (OTC PINK: FILM) (the "Company" or "Cre8tive") would…

Continue Reading

Ord Mountain Resources Corp. Announces Extension to Business Combination Agreement and Re-Prices Private Placement Financing

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/29/17 -- ORD MOUNTAIN RESOURCES CORP. ("Ord") (NEX: OMR.H), a…

Continue Reading

Youngevity Acquires BellaVita

Acquisition Strengthens Youngevity Asian Market Presence

Continue Reading

Akers Biosciences Announces Conference Call to Discuss FY 2016 Earnings

THOROFARE, NJ -- (Marketwired) -- 03/29/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company"…

Continue Reading

Ritter Pharmaceuticals Announces Lactose Intolerance Treatment, RP-G28, Demonstrated Efficacy and Clinically Meaningful Benefit in Phase 2b/3 Clinical Trial

LOS ANGELES, CA -- (Marketwired) -- 03/28/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR)Data Supports Further Clinical…

Continue Reading

Metrospaces Announces Restructuring of Assets and Refocus of Business Plan to the U.S.A.

MIAMI, FL -- (Marketwired) -- 03/28/17 -- Metrospaces, Inc. (OTC PINK: MSPC) announces the restructuring of…

Continue Reading

Cognoa Raises $11.6 Million, Reaching More Than $20 Million Invested to Advance Earlier Diagnosis of Developmental Delays in Children

Cognoa leads the charge in leveraging machine learning and patient reported outcomes to detect early signs…

Continue Reading

Akers Biosciences Begins Selling Rapid Cholesterol Test through Distribution Agreement with First Check

THOROFARE, NJ -- (Marketwired) -- 03/28/17 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company"…

Continue Reading